CN1059575C - Traditional Chinese medicine- - Google Patents
Traditional Chinese medicine- Download PDFInfo
- Publication number
- CN1059575C CN1059575C CN96109694A CN96109694A CN1059575C CN 1059575 C CN1059575 C CN 1059575C CN 96109694 A CN96109694 A CN 96109694A CN 96109694 A CN96109694 A CN 96109694A CN 1059575 C CN1059575 C CN 1059575C
- Authority
- CN
- China
- Prior art keywords
- present
- radix
- chinese medicine
- medicine
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a Chinese medicine for treating cancer, which is prepared from milkvetch root, ginseng, deer horn, pberetima, scorpion, oldenlandia, tortoise plastron, notoginseng, zedoray rhizome, arnebia root, common prism tuber, oyster shell, seaweed and sal ammoniac. The present invention has the functions of softening and resolving hard mass, activating blood for dissolving stasis, supporting healthy energy to eliminate pathogen, clearing away heat and toxic material, and strengthening the spleen and the stomach. The present invention can obviously influence patient's tumors, and has good functions for removing and improving patient's cachexia. The present invention has the advantages of wide medicine source, low cost, conspicuous curative effect.
Description
The present invention relates to a kind of Chinese medicine that is used for the treatment of cancer.
Cancer is very high commonly encountered diseases of world today's M ﹠ M and difficult disease, still lacks the specific treatment means so far.Chemotherapy and radiation method commonly used has fettered its life-time service and has produced a desired effect because of it inevitably can cause the numerous bad reflection based on hemopoietic system and immune system infringement.More people likes adopting Chinese medicine to treat or auxiliary for treating cancer, and the most curative effect of various Chinese medicines of existing treatment cancer is obviously enough unavoidably, the employing rare Chinese medicine that takes effect slow or more, and expenses for medicine is higher.
Purpose of the present invention overcomes above-mentioned the deficiencies in the prior art exactly, and the Chinese medicine of the treatment cancer that a kind of medicine source is extensive, cost is low and evident in efficacy is provided.
In order to achieve the above object, the present invention adopts the medicine of resolving phlegm and softening hard masses and blood circulation promoting and blood stasis dispelling, is beneficial to dwindling and eliminating of tumor body; Adopt the antipyretic and antidotal type medicine to help dispeling of poison; The medicine of reinforcing spleen and kidney, benefiting QI and nourishing blood then helps the reflex of healthy energy, and positive what is called is set upright with eliminating evil.In addition, Radix Ginseng contains the material of anticancer growth, and the growth of ehrlich carcinoma is had inhibitory action; Herba Hedyotidis Diffusae all has obvious inhibitory action to ehrlich carcinoma, yoshida sarcoma etc.; Rhizoma Curcumae has better curative effect to sarcoma, and QI invigorating such as the Radix Astragali, invigorate blood circulation, reduce phlegm, heat clearing away class medicine, have the cellular immunization of enhancing and humoral immune function mostly, improve the effect of organismic internal environment.The present invention adopts the Radix Astragali, Radix Ginseng, Cornu Cervi, Gekko Swinhonis, Scorpio, Herba Hedyotidis Diffusae, Carapax et Plastrum Testudinis, Radix Notoginseng, Rhizoma Curcumae, Radix Arnebiae (Radix Lithospermi), rhizoma sparganic, Concha Ostreae, Sargassum, Sal Ammoniacus to form, and has stronger hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, strengthening vital QI to eliminate pathogenic factors, heat-clearing and toxic substances removing, invigorating the spleen and regulating the stomach function.The present invention's prescription by part (part is unit of weight) is:
Radix Astragali 10-15, Radix Ginseng 6-10, Cornu Cervi 1-2, Gekko Swinhonis 3-6, Scorpio 6-9, Herba Hedyotidis Diffusae 12-18, Carapax et Plastrum Testudinis 3-6, Radix Notoginseng 1-3, Rhizoma Curcumae 3-6, Radix Arnebiae (Radix Lithospermi) 15-20, rhizoma sparganic 6-9, Concha Ostreae 20-30, Sargassum 15-20, Sal Ammoniacus 0.3-0.6.
Preparation method of the present invention is to choose authentic medicinal herbs, follows the prescribed rules respectively by " pharmacopeia " regulation, is ground into fine powder, crosses 180 mesh sieves, and method for making gets final product routinely.
Instructions of taking is secondary every day, each 10 gram powder, and per stage is 12 days, and drug withdrawal was had a rest two days between two stages, and three phases is a course of treatment.Period in a medicine can be equipped with support and symptomatic treatments such as liquid, infection.
The patient treats three courses of treatment continuously, and after leaving hospital, follow up a case by regular visits to once every year.The criterion of observe the curative effect is: produce effects is a clinical symptom disappearance, and image check shows that the tumor body dwindles, and follows up a case by regular visits to alive.Effectively obviously improve for clinical symptoms, image check shows that the tumor body does not increase, and do not have to shift, and the state of an illness does not have and increases the weight of and worsen, and follows up a case by regular visits to the existence of lotus tumor after leaving hospital 1 year.Invalidly improve not obvious or only have slight improvement, image check to show that the tumor body enlarges or shifts for clinical symptoms, increase the weight of during the treatment, dead, use other therapies instead or leave hospital dead in back 1 year.
The present invention is through a large amount of clinical observations, and total effective rate reaches 95%, and obvious effective rate reaches 52.5%.Clinical observation shows, the present invention has good action to the cachexia of eliminating or improve the cancer patient (expendable sign), the original severe cachexia in treatment back has obviously and alleviates, in original, mild then can improve or disappear, illustrate that this medicine can obviously improve cancer patient's body constitution and life quality, have laid a good foundation for further treating.The present invention also can obviously influence patient's tumor body, has quite a few to dwindle, thereby can improve cancer patient's therapeutic effect greatly.
The better embodiment of the present invention is: Radix Astragali 15g, Radix Ginseng 10g, Cornu Cervi 1.5g, Gekko Swinhonis 6g, Scorpio 6g, Herba Hedyotidis Diffusae 15g, Carapax et Plastrum Testudinis 3g, Radix Notoginseng 1.5g, Rhizoma Curcumae 5g, Radix Arnebiae (Radix Lithospermi) 18g, rhizoma sparganic 9g, Concha Ostreae 25g, Sargassum 18g, Sal Ammoniacus 0.5g.Grind into powder and make powder, the pack sterilization, every bag heavy 10 gram,
Medicine of the present invention source is extensive, cost is low, evident in efficacy, be mainly used in the treatment of digestive system, respiratory system, urinary system and gynecological cancer, other cancer is also had adjuvant treatment effect preferably.
Claims (1)
1, a kind of Chinese medicine for the treatment of cancer is characterized in that being made up of the raw material of following weight portion:
Radix Astragali 10-15, Radix Ginseng 6-10, Cornu Cervi 1-2, Gekko Swinhonis 3-6, Scorpio 6-9, Herba Hedyotidis Diffusae 12-18, Carapax et Plastrum Testudinis 3-6, Radix Notoginseng 1-3, Rhizoma Curcumae 3-6, Radix Arnebiae (Radix Lithospermi) 15-20, rhizoma sparganic 6-9, Concha Ostreae 20-30, Sargassum 15-20, Sal Ammoniacus 0.3-0.6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96109694A CN1059575C (en) | 1996-09-18 | 1996-09-18 | Traditional Chinese medicine- |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96109694A CN1059575C (en) | 1996-09-18 | 1996-09-18 | Traditional Chinese medicine- |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1176795A CN1176795A (en) | 1998-03-25 |
| CN1059575C true CN1059575C (en) | 2000-12-20 |
Family
ID=5120527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96109694A Expired - Fee Related CN1059575C (en) | 1996-09-18 | 1996-09-18 | Traditional Chinese medicine- |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1059575C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1068523C (en) * | 1998-08-28 | 2001-07-18 | 周伟 | Medicine for treating cancer and its preparing technology |
| CN101264268B (en) * | 2008-05-05 | 2011-07-13 | 李安治 | Proprietary Chinese medicine for treating tumor |
-
1996
- 1996-09-18 CN CN96109694A patent/CN1059575C/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 中西医结合肝病杂志1995,5(4) 1995.1.1 周正清，中西医结合治疗胃癌术后肝转移53例 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1176795A (en) | 1998-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1051237C (en) | Meicinal prepn. "Kexianling" for curing epilepsy | |
| CN102106923A (en) | Chinese medicinal preparation for treating osteoporosis | |
| CN111643637B (en) | Traditional Chinese medicine composition for preventing and treating chronic atrophic gastritis and gastric precancerous lesions and preparation method and application thereof | |
| CN101041043A (en) | Liver cancer treating traditional Chinese medicine | |
| CN101711848B (en) | Chinese medicinal composition capable of adjunctively treating tumour | |
| CN101695555B (en) | Medicament composition for treating prostatitis and prostatomegaly and preparation method thereof | |
| CN103638190B (en) | The Chinese medicine for the treatment of acute cholecystitis | |
| CN1059575C (en) | Traditional Chinese medicine- | |
| CN1048409C (en) | Capsule for protecting liver and eliminating tumor | |
| CN104147388B (en) | Traditional Chinese medicine composition for treating migraine and preparation method thereof | |
| CN102100849B (en) | Chinese medicine preparation for treating lumbar disc herniation and preparation method thereof | |
| CN1052889C (en) | Chinese proprietary for curing hepatitis | |
| CN104547736A (en) | Medicine for treating goiter | |
| CN106177639A (en) | One treats psoriatic Chinese medicine composition and preparation method thereof | |
| CN101647981B (en) | Drug for treating blood-deficiency and wind-dry type psoriasis | |
| CN104825991A (en) | Traditional Chinese medicine preparation for alcoholism induced mental disorder, and preparation method thereof | |
| CN110638955A (en) | Chinese medicinal composition for treating arthralgia | |
| CN1907318A (en) | Use of ceylon houndstongue and pharmaceutical composition containing same | |
| CN100382833C (en) | Mastosis treating Chinese medicine | |
| CN1428158A (en) | Chinese medicine for curing gastropathy | |
| CN102940806B (en) | Chinese medicinal composition for treating hyperlipidemia | |
| CN101554461B (en) | Medicine for treating psoriasis and preparation method of capsule thereof | |
| CN1733190A (en) | Chinese traditional medicine preparation for curing mastopathy in installments | |
| CN105998519A (en) | Oral medicine for treating frequent micturition due to pelvic inflammatory disease | |
| CN1059574C (en) | Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |